Seattle Genetics

Seattle Genetics is a biotechnology company specializing in developing targeted cancer therapies using antibody-drug conjugates (ADCs). These treatments combine antibodies that specifically recognize cancer cells with powerful drugs, delivering the medication directly to tumors while minimizing harm to healthy tissue. This approach aims to improve treatment effectiveness and reduce side effects. The company is also involved in research to expand its pipeline of innovative cancer therapies. Based in Seattle, Washington, Seattle Genetics collaborates with other biotech and pharmaceutical companies to advance cancer treatment options.